DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Kienel A, Porres D, Heidenreich A. et al.
cfDNA as a Prognostic Marker of Response to Taxane Based Chemotherapy in Patients with Prostate Cancer.
The Journal of urology 2015;
194: 966-971
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.